BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20702003)

  • 21. Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Cervino AR; Vinante L; Al-Nahhas A; Rubello D; Muzzio PC; Polverosi R
    J Med Imaging Radiat Oncol; 2012 Aug; 56(4):417-24. PubMed ID: 22883649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M
    Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.
    Gupta NC; Maloof J; Gunel E
    J Nucl Med; 1996 Jun; 37(6):943-8. PubMed ID: 8683316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [PET/CT: focal lung uptake of 18F-fluorodeoxyglucose on PET but no structural alterations on CT].
    Sánchez-Sánchez R; Rodríguez-Fernández A; Ramírez-Navarro A; Gómez-Río M; Ramos-Font C; Llamas-Elvira JM
    Rev Esp Med Nucl; 2010; 29(3):131-4. PubMed ID: 20227797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory gating enhances imaging of pulmonary nodules and measurement of tracer uptake in FDG PET/CT.
    Werner MK; Parker JA; Kolodny GM; English JR; Palmer MR
    AJR Am J Roentgenol; 2009 Dec; 193(6):1640-5. PubMed ID: 19933659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography of incidentally detected small pulmonary nodules.
    Fischer BM; Mortensen J; Dirksen A; Eigtved A; Højgaard L
    Nucl Med Commun; 2004 Jan; 25(1):3-9. PubMed ID: 15061259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET in lung cancer.
    Coleman RE
    J Nucl Med; 1999 May; 40(5):814-20. PubMed ID: 10319756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.
    Evangelista L; Panunzio A; Polverosi R; Pomerri F; Rubello D
    AJR Am J Roentgenol; 2014 Mar; 202(3):507-14. PubMed ID: 24555586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
    Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
    Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating PET and CT information to improve diagnostic accuracy for lung nodules: A semiautomatic computer-aided method.
    Nie Y; Li Q; Li F; Pu Y; Appelbaum D; Doi K
    J Nucl Med; 2006 Jul; 47(7):1075-80. PubMed ID: 16818939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep Inspiration Breath Hold [(18)F]FDG PET-CT on 4-rings scanners in evaluating lung lesions: evidences from a phantom and a clinical study.
    Caobelli F; Puta E; Kaiser SR; Massetti V; Andreoli M; Mostarda A; Soffientini A; Pizzocaro C; Guerra UP
    Rev Esp Med Nucl Imagen Mol; 2014; 33(3):136-47. PubMed ID: 24268841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT.
    Ohno Y; Nishio M; Koyama H; Seki S; Tsubakimoto M; Fujisawa Y; Yoshikawa T; Matsumoto S; Sugimura K
    Radiology; 2015 Feb; 274(2):563-75. PubMed ID: 25203128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in quantitative parameters of pulmonary nonsolid nodule induced by lung inflation according to paired inspiratory and expiratory computed tomography imaging.
    Fan L; Li Q; Tu W; Chen R; Xia Y; Pu Y; Li Z; Liu S
    Eur Radiol; 2019 Aug; 29(8):4333-4340. PubMed ID: 30689035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
    Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
    Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.